Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
X4 Pharmaceuticals Inc
NASDAQ:XFOR
Price:
3.07
USD
-5.25%
Market Cap:
$304.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
H
|
Hurxley Corp
TSE:7561
|
JP |
|
D
|
Deutsche Telekom AG
SWB:DTE
|
DE |
|
Eastern International Ltd
NASDAQ:ELOG
|
CN |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
P
|
Publicis Groupe SA
DUS:PU4
|
FR |
|
UniCredit SpA
MIL:UCG
|
IT |
Wall St Price Targets
XFOR Price Forecast
Based on 7 analysts
Based on 7 analysts
+299% Upside
from
$3.07
today
X4 Pharmaceuticals Inc (XFOR)’s 12-month stock price forecast through November 2027 has a consensus target of $12.24, implying 299% upside. The forecast is based on price targets from 7 Wall Street analysts.
XFOR Analyst Rating
Based on 5 analysts
Based on 5 analysts
Analysts rate XFOR Strong buy, with 5 of 5 recommending Buy or Strong buy.
X4 Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XFOR's stock price target?
Price Target
12.24
USD
12.24
USD
According to Wall Street analysts, the average 1-year price target for XFOR is 12.24 USD with a low forecast of 10.1 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for X4 Pharmaceuticals Inc?
Projected CAGR
46%
46%
The compound annual growth rate for Revenue over the next 7 years is 46%.
What is the Gross Profit forecast for X4 Pharmaceuticals Inc?
Projected CAGR
48%
48%
The compound annual growth rate for Gross Profit over the next 7 years is 48%.
